Daiichi will seek up to $2.3bn for Ranbaxy

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Daiichi will seek up to $2.3bn for Ranbaxy

Japanese pharmaceutical group Daiichi Sankyo may borrow up to $2.3bn to finance its purchase of a majority stake in Ranbaxy Laboratories, India’s biggest generic drug maker, EuroWeek has learned.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article